Executive Summary
Following 9/11 and the anthrax letters in 2001, the field of biodefense
significantly expanded to address global health, public health preparedness and response, medical countermeasure development, and civilian biological research, some of which includes select agents . The increasing investment in biodefense and concern about a bioterrorism attack within the United States and abroad suggests that the landscape for biodefense policy issues and workforce needs continue to evolve.